Skip Navigation


ToxSci Advance Access originally published online on March 15, 2007
Toxicological Sciences 2007 97(2):375-383; doi:10.1093/toxsci/kfm053
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
97/2/375    most recent
kfm053v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fairley, K. J.
Right arrow Articles by Meade, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fairley, K. J.
Right arrow Articles by Meade, B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press 2007.

Exposure to the Immunosuppresant, Perfluorooctanoic Acid, Enhances the Murine IgE and Airway Hyperreactivity Response to Ovalbumin

Kimberly J. Fairley*, Rich Purdy{dagger}, Shaun Kearns*, Stacey E. Anderson* and BJ Meade*,1

* National Institute for Occupational Safety and Health, Morgantown, West Virginia 26505 {dagger} Baldur Toxicology, N7659 950th Street, River Falls, Wisconsin 54022

1 To whom correspondence should be addressed at 1095 Willowdale Road, MS 4020, Morgantown, WV 26505. E-mail: bhm8{at}cdc.gov.

Received January 18, 2007; accepted March 8, 2007


   Abstract

These studies were conducted to investigate the role of dermal exposure to perfluorooctanoic acid (PFOA), a known immunosuppressant, on the hypersensitivity response to ovalbumin (OVA) in a murine model of asthma. PFOA has had widespread use as a carpet and fabric protectant. BALB/c mice were exposed dermally, on the dorsal surface of each ear, to concentrations of PFOA ranging from 0.01 to 1.5% (applied dose 0.25–50 mg/kg) for 4 days. In hypersensitivity studies, mice were also ip injected with 7.5 µg OVA and 2 mg alum on days 1 and 10 and in some studies challenged with 250 µg OVA by pharyngeal aspiration on days 17 and 26. Following exposure to PFOA, an increase in liver weights and a decrease in thymus and spleen weights and cellularities were observed. Similar immunomodulatory trends were demonstrated in mice coadministered PFOA and OVA. Compared to the OVA alone–exposed animals, an increase in total IgE was demonstrated when mice were coexposed to OVA and concentrations of PFOA ranging from 0.75 to 1.5%, while the OVA-specific IgE response peaked with 0.75% PFOA coexposure (p ≤ 0.05). OVA-specific airway hyperreactivity was increased in the 1.0% PFOA coexposed group (p ≤ 0.05), with an increased pleiotropic cell response characterized by eosinophilia and mucin production, in animals coexposed to concentrations of PFOA up to 1.0%, as compared to the OVA alone–exposed animals. In a murine model, PFOA was demonstrated to be immunotoxic following dermal exposure, with an enhancement of the hypersensitivity response to OVA, suggesting that PFOA exposure may augment the IgE response to environmental allergens.

Key Words: perfluorooctanoic acid; ovalbumin; airway hyperreactivity; IgE.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol SciHome page
S. E. Loveless, D. Hoban, G. Sykes, S. R. Frame, and N. E. Everds
Evaluation of the Immune System in Rats and Mice Administered Linear Ammonium Perfluorooctanoate
Toxicol. Sci., September 1, 2008; 105(1): 86 - 96.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. Lau, K. Anitole, C. Hodes, D. Lai, A. Pfahles-Hutchens, and J. Seed
Perfluoroalkyl Acids: A Review of Monitoring and Toxicological Findings
Toxicol. Sci., October 1, 2007; 99(2): 366 - 394.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.